Aqilion is a Swedish life science company. We believe the best source of new treatments comes from identifying, shaping and strengthening early drug innovation. We seek ideas that could potentially both improve patient quality of life and streamline health care.
Aqilion harbors the backbone core management, financing resources and business administration together with a network of skilled competences and seek to match that with external sources of innovation from academia or industry.
Aqilion pursues and transforms ideas aimed at testing and refining science into clinical translation. The goal is to deliver clinical proof-of-concept and an interesting value proposition to attract industrial partners fitted to drive the late phases of clinical development and commercialization.
Company Details
- Employees
- 17
- Address
- Redaregatan 48, Helsingborg,skane County 25236,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aqilion.com
- Keywords
- Drug discovery, Chronic inflammation, Autoimmune diseases, Small molecules, Eosinophilic esophagitis, ulcerative colitis, T cell biology.
- HQ
- Helsingborg, Skane County
Aqilion Ab Questions
Aqilion Ab's website is aqilion.com
Aqilion Ab's LinkedIn profile is https://se.linkedin.com/company/aqilion
Aqilion Ab has
17 employees.
View email and phone details for 17
employees at Aqilion Ab.
Aqilion Ab's industry is
Biotechnology Research
Aqilion Ab's top competitors are
Ventures Accelerated Life Science,
Ribocure Pharmaceuticals Ab,
Bioinvent International Ab,
Asgard Therapeutics,
Pelago Bioscience Ab,
Galecto, Inc.,
Rg Discovery,
Flerie,
Active Biotech Ab,
Abliva Ab.
Aqilion Ab's categories are Biotechnology Research
